Spine – Page 39 – Selby Spine

MARIETTA, GA. (PRWEB) NOVEMBER 28, 2017

Spinal Elements, Inc. today announced plans to move its global headquarters to its Carlsbad, California location. Concurrent with this move, Jason Blain, co-founder of Spinal Elements and currently its President and COO, will assume the role of President and CEO. This change is effective immediately.

“I am excited by the opportunity to lead our talented team of employees and partners and create an even more vibrant and dynamic Spinal Elements in the years to come,” said Jason Blain, Spinal Elements’ new President and CEO. “I thank Chris Fair and the other members of our board of directors for their confidence. Going forward, Spinal Elements will continue to be focused on innovation and execution, driven by differentiated technologies and premium customer service, and we will move quickly to scale new ideas and opportunities into this dynamic marketplace.”

The company’s headquarters move will have minimal impact on Spinal Elements’ Marietta, Georgia-based operations and employees. Added Blain, “The company remains committed to its Marietta campus and our employees based there.”

Mr. Blain’s ascension to CEO will build on the strong foundation and momentum achieved by the Spinal Elements team under Chris Fair’s leadership. “Jason has inspired many of Spinal Elements’ most exciting technologies – past, present and future – while also fostering a team-oriented culture in each position he has held during his career,” said Mr. Fair. “I look forward to supporting Jason and the company across all future endeavors.” Mr. Fair, who resides with his family in the Atlanta metro area, will continue as a member of Spinal Elements’ Board of Directors.

Prior to co-founding Spinal Elements in 2003, Mr. Blain had roles of increasing responsibility in product development, manufacturing, regulatory affairs and quality assurance with Smith & Nephew, Alphatec, and NuVasive.

About Spinal Elements

Spinal Elements is an outcomes-driven spinal surgical solutions company with locations in Carlsbad, CA and Marietta, GA. A leading designer, developer, manufacturer and marketer of innovative medical devices used in spinal surgical procedures, our mission is to combine leading medical device technologies, biologics and instrumentation to create positive surgical outcomes that exceed surgeon and patient expectations. For more information, please visit http://www.spinalelements.com.

ROSWELL, GA. (PRWEB) NOVEMBER 28, 2017

Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal application by utilizing additive manufacturing, announces that it has now performed the first surgeries in the United States and is able to offer all interbody products for Cervical, ALIF, TLIF and PLIF procedures.

EIT Cellular Titanium® is a 3D printed porous titanium structure that has been designed according to scientific insights on ideal pore shape and size to optimize cell proliferation and bone ingrowth.

The first surgeons to implant this novel cage technology were:

Matthew Gornet, orthopaedic spine surgeon at St. Louis Spine and Orthopedic Surgery Center
Gurvinder Deol, orthopaedic spine surgeon at Wake Orthopaedics
Faheem Sandhu, orthopaedic spine surgeon at Georgetown University
Brandon Scott, orthopaedic spine surgeon at Saint Francis Medical Center

Since that time, EIT has experienced incredible adoption throughout the country and has exceeded initial case volume projections by 250%.

As to why these cages have been so appealing to U.S. surgeons, the initial surgeons have said the following:

Matthew Gornet, MD, a fellowship-trained spine surgeon from Johns Hopkins Hospital as well as author of several published book chapters and research papers said, “I am excited to use this new technology to enhance the outcomes of my patients.”

Dr. Gurvinder S. Deol, MD, is a board certified (FAAOS), fellowship-trained Orthopedic Spine Surgeon for Wake Orthopaedics in Raleigh, NC said “The large surface of cellular porous structure combined with encouraging data from over 15,000 implants throughout Europe and many international markets make a lot of sense to me.”

Faheem Sandhu MD, PhD, is director of spine surgery at MedStar Georgetown University Hospital and professor of neurological surgery at Georgetown University Medical Center said, “I’m very excited about porous titanium cages and the possibility for improving fusion rates while reducing the need for biologic agents.”

Brandon Scott, MD. at Saint Francis Healthcare System is a Neurosurgeon in Cape Girardeau, Missouri. said, “The adaptation of the design of the cervical cage to the cervical anatomy is very nice and allows me to have a perfect fit of the implant with high primary stability.”

“We are thrilled to be working with these thought-leading surgeons since our initial product launch at NASS. The market response and adoption exceeds our expectations by far,” said Guntmar Eisen, cofounder and CEO of EIT.
________

About EIT

EIT is the first medical device manufacturer to exclusively focus on implants for spinal alignment, that are designed according to latest published science on optimal bone ingrowth in porous titanium scaffolds and produced with additive manufacturing methods. EIT was founded in 2014 by Hans Eekhof and Guntmar Eisen.

The EIT implants are made of EIT Cellular Titanium®, that addresses the clinical shortcomings of the current cage designs and materials (non-fusion, biocompatibility, subsidence, migration and imaging distortion), thereby obtaining very promising fusion results and improved clinical outcome due to the qualities of the porous 3-D printing of titanium. The highly porous titanium scaffold ensures extensive bone ingrowth as a result of its specific design and elasticity close to the cancellous bone. Due to its unique design with a porosity of 80% the EIT implants ensure uncompromised imaging on X-ray and MRI and enabling excellent follow up on defining bone ingrowth and fusion with CT.

A complete portfolio of Smart Spinal Implants™ based on EIT Cellular Titanium® is available for the cervical and lumbar spine, with an extensive choice in footprint sizes, heights and lordosis angles to support the recreation of sagittal balance and alignment. Since 2014 over 10.000 EIT cases have been performed in over 15 markets globally.

November 28, 2017

NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD™ Adaptive Spine Intelligence™ (ASI) technology, announced today the Company has acquired three patents from Dr. Paul McAfee, of University of Maryland St. Joseph’s Medical Center. These patents cover the methodology used to measure and plan interbody devices used in spinal surgery.

The three patents acquired from Dr. McAfee protect the associated intellectual property around a novel technique for physiologically selecting interbody device height based on patient anatomy to further enhance Medicrea’s UNiD™ ASI platform.

Dr. McAfee stated, “Medicrea is uniquely positioned to benefit from this intellectual property to enhance their industry-leading surgical planning service. Surgeons understand that the effective use of interbody devices plays an important role in determining outcomes for spinal patients and spend significant time intra-operatively testing for the ‘best-fitting’ interbody device based on a limited range of dimensions provided by legacy manufacturers. However, this current technique often leads to compromise between two available interbody dimensions and lacks scientific rationale. Knowing the level of inventory required to deliver a range meeting patient needs in every case is cost-prohibitive for even the largest legacy manufacturers. There is a clear demand for the reliable planning tools and services available with UNiD™ ASI.”

Medicrea’s systems-based approach to spine with engineering services and in-house 3D-Printing capabilities makes the Company uniquely able to deeply collaborate with surgeons to create interbody device solutions that are adapted to their clinical and mechanical preferences, as demonstrated by the recent FDA clearance of the Company’s IB3D™ offering of 3D-printed Titanium interbody devices with AdapTEK™, surgeon-adaptive technology for unparalleled control of the implant design and dimensions provided.

Denys Sournac, President and Chief Executive Officer, stated, “We are focused on fully integrating the important work done by Dr. McAfee into our proprietary UNiD™ HUB surgical planning software. Combining data-driven planning techniques with the ability to deliver personalized implants will significantly reduce the inventory required for each case while ensuring the optimal implant is provided for the patient at each level operated. Acquiring new planning methodologies, as we have done with Dr. McAfee, will allow Medicrea to further provide healthcare shareholders with scientific evidence supporting the surgical strategy and promoting a cost-effective care continuum in line with our Adaptive Spine Intelligence™ technology.”

About Medicrea (www.Medicrea.com)

Through the lens of predictive medicine, Medicrea leads the design, integrated manufacture, and distribution of 30+ FDA approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. By leveraging its proprietary software analysis tools with big data and machine learning technologies and supported by an expansive collection of clinical and scientific data, Medicrea is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room.

Operating in a $10 billion marketplace, Medicrea is a Small and Medium sized Enterprise (SME) with 175 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants.

For further information, please visit: Medicrea.com.

Connect with Medicrea:
FACEBOOK | INSTAGRAM | TWITTER | WEBSITE | YOUTUBE

Medicrea is listed on
EURONEXT Growth Paris
ISIN: FR 0004178572
Ticker: ALMED
LEI: 969500BR1CPTYMTJBA37

Contacts

Medicrea
Denys Sournac
Founder, Chairman and CEO
dsournac@Medicrea.com
or
Fabrice Kilfiger, +33 (0)4 72 01 87 87
Chief Financial Officer
fkilfiger@Medicrea.com

e7a9a9f3-3d91-43db-9059-6319dedb39c0-original-e1511809902418.png

November 21, 2017

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the alpha launch of the SIMPACT TRI-FIN Sacroiliac Joint Fixation Screw System.

“I am excited to add SIMPACT TRI-FIN to our growing portfolio of MIS Procedural Solutions, as well as providing surgeons an additional surgical option for sacroiliac joint fixation. SIMPACT TRI-FIN is unique in that it offers helical cutting flutes designed for faster and easier insertion, as well as a design that allows the screw to harvest local bone while being implanted across the SI joint,” said Mariusz Knap, Vice President of Marketing and Business Development for Life Spine.

The SIMPACT TRI-FIN system was designed with an anti-rotational sleeve to inhibit component back out, and a screw thread design which affords the surgeon the ability to compress and stabilize the SI joint.

SIMPACT TRI-FIN also continues the use of Life Spine’s OSSEO-LOC technology. OSSEO-LOC is a proprietary surface treatment that creates a unique osteophylic surface architecture for potential bone on-growth.¹ The unique surface architecture promotes mineralization of implant, while negating potential challenges associated with surface treated implants.²

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com.

Life Spine is a registered trademark.

¹Feighan, J.E., Goldberg, V.M., Davy, D., Parr, J.A., Stevenson, S.
“The Influence of Surface Blasting on the Incorporation of Titanium-Alloy Implants in a Rabbit Intramedullary Model.” The Journal of Bone and Joint Surgery 77.9 (1995): 1380-96. Web.

²K.Kieswetter, Z. Schwartz, T. W. Hummert, D. L. Cochran, J. Simpson and B. D. Boyan
“Surface roughness modulates the local production of growth factors by osteoblast-like MG-62 cells” The Journal of Biomedical Materials Research (1996): Web.

Contacts

Life Spine
Omar Faruqi
Chief Financial Officer
ofaruqi@lifespine.com
847-884-6117

WARSAW, Ind., Nov. 27, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is a Platinum sponsor of the 14th Annual International Pediatric Orthopaedic Symposium (IPOS), taking place November 28 to December 2, 2017 in Orlando, Florida. The IPOS meeting, presented by the Pediatric Orthopaedic Society of North America (POSNA) and the American Academy of Orthopaedic Surgeons (AAOS), brings together hundreds of pediatric orthopedic surgeons from around the world.

As part of OrthoPediatrics’ commitment to leading innovation in pediatric orthopedics and fostering clinical education, the company is actively engaged in all aspects of the meeting. This includes sponsoring a pre-course meeting on “The Surgical Treatment of Hip Dysplasia in Older Children and Adolescents.” The Company will also host four interactive workshops, highlighting new technology and surgical techniques in Trauma, Deformity Correction, Sports Medicine/Soft Tissue Repair and Scoliosis care.

Mark Throdahl, President and CEO of OrthoPediatrics, said, “OrthoPediatrics’ goal is to advance the field of pediatric orthopedics with the broadest and most innovative product line in our industry. Our surgical systems, coupled with our focus on clinical education, are at the very core of our business. We are excited for our continued partnership with organizations like POSNA and look forward to returning to the IPOS meeting for another successful year.”

OrthoPediatrics will be highlighting its products at booth #104 at the IPOS meeting.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is the only diversified orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market. OrthoPediatrics is dedicated to the cause of improving the lives of children with orthopedic conditions. OrthoPediatrics currently markets 22 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, complex spine and ACL reconstruction procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 35 countries outside the United States.

Investor Contact
The Ruth Group
Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com

ROCKVILLE, Md., Nov. 22, 2017 /PRNewswire/ — According to Europe Market Report for Spinal Motion Preservation Devices 2017 – MedCore by iData Research, Inc., procedural growth, favorable reimbursement policies, and its use as an alternative to spinal fusion are driving the European cervical artificial disc market. Growth rates will be maintained due to increased adoption rates and patient education. The total artificial disc market represents a growing share of the overall motion preservation device market which includes cervical and lumbar artificial discs as well as dynamic posterior stabilization and interspinous process decompression devices.

Growth of the motion preservation market has been attributed to the continued expansion of the artificial disc market. Growth of the artificial disc market will be further fueled by cervical artificial discs (CADs) due to their simpler approach, favorable clinical results and lower average selling prices (ASPs), along with a favorable reimbursement environment.

“The CAD market grew driven by the more recent emergence of the technology, in addition to the available literature supporting the procedure,” explains Jeffrey Wong, Strategic Analyst Manager at iData Research. “The artificial disc market will continue to exhibit growth due to newer CAD devices, which will increase the prevalence and popularity of artificial discs in the market.”

Spinal Kinetics and DePuy Synthes currently lead the European market for cervical and lumbar artificial discs. DePuy Synthes’ presence is supported by brand recognition and loyalty towards their ProDisc®-L and ProDisc®-C lines of products. However, DePuy Synthes’ position will continue to be challenged with the recent emergence of numerous new products and competitors. Spinal Kinetics continues to make gains in the European market with the M6®-C and M6®-L artificial discs. These devices were the first to replicate the anatomic and biomechanical attributes of a natural intervertebral disc.

Additional competitors include Medtronic, Zimmer Biomet, Paradigm Spine, Globus Medical, Cousin Biotech, Ulrich Medical and SpineVision.

Total Unit Sales, Average Selling Prices, Market Value and Growth Trends are segmented in terms of:

Total Motion Preservation Device Market
Artificial Disc Market
- Cervical Artificial Disc Market
- Lumbar Artificial Disc Market
Dynamic Stabilization Market
- Dynamic Posterior Stabilization Device Market
- Interspinous Process Decompression Device Market

All above analyzed for each of 10 regions in Europe (Germany, France, UK, Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal).

More information about the report is available at
https://www.marketresearch.com/iData-Research-Inc-v3689/Europe-Spinal-Motion-Preservation-Devices-11005898/

About iData Research
iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Trauma, Large & Small Joints, Wound Management, Orthopedic Soft Tissue, Orthopedic Biomaterials, Orthopedic Soft Tissue Reinforcement and Regeneration, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Ophthalmics, Vascular Access, Laparoscopy, Urology, Gynecology, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Anesthesiology, Orthopedics and more.

We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.

About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world’s most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com’s Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance.

Press Contact:
Corinne Gangloff
+1 440.684.9600
cgangloff@marketresearch.com

SOURCE MarketResearch.com

Contacts

EOS imaging
CFO
Pierre Schwich, +33 (0)1 55 25 61 24
investors@eos-imaging.com
or
NewCap
Financial communication and investor relations
Pierre Laurent, +33 (0)1 44 71 94 96
eosimaging@newcap.eu
or
The Ruth Group (US)
Press relations
Joanna Zimmerman, 646-536-7006
jzimmerman@theruthgroup.com

NEW YORK, Nov. 20, 2017 /PRNewswire/ — Paradigm Spine, LLC, a leader in providing solutions for the treatment of lumbar spinal stenosis announces issuance of a Highmark, Inc. Medical Policy, entitled “Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)” dated November 6, 2017. The coverage policy may be found here https://www.highmarkbcbswv.com/west-virginia-commercial-medical-policy/S-191-016.html

Importantly, the Medical Policy specifically excludes any other interspinous distraction or interlaminar stabilization devices, other than the coflex^® device, from coverage. Highmark, Inc. is the first commercial insurance carrier to provide exclusive coverage for the coflex^® device, due to the more than 85 peer-reviewed published articles supporting the safety and effectiveness of the coflex^® technology.

Lumbar spinal stenosis (“LSS”), affecting 1.6 million patients annually, is a debilitating and degenerative disease in older patients (>50 yrs) often associated with significant leg and back pain, leg numbness and weakness, causing a significant reduction in an active lifestyle. Traditional surgical treatment options for LSS includes a decompression that removes bone and soft tissue and may also require a fusion to stabilize the spine. The coflex^® device is a non-fusion, motion preserving stabilization implant, that is FDA PMA approved for the treatment of Lumbar Spinal Stenosis, and can be used in conjunction with a decompression or used in lieu of a spinal fusion.

To learn more about coflex^® Interlaminar Stabilization^®, please visit www.coflexsolution.com.

J. Rush Fisher, MD, Chief of Spine Section, Christiana Care Health Services – “Over the last four years, I’ve treated 67 patients with coflex^® and have been very satisfied with the outcomes. Coflex^® offers stability to the spine while maintaining physiologic function to the motion segment. The coflex^® procedure is often an outpatient, non-fusion procedure that allows for fast recovery, and a high quality functionally active lifestyle for my patients. I’m understandably pleased that insurance coverage will now be available to more of my patients.”

Marc Viscogliosi, Chairman & CEO – “With over 85 peer-review published articles, including landmark 5 year follow-up studies, medical society guidelines, and now with commercial insurance coverage, it is wonderful to be able to expand patient access to the coflex^® technology. We are particularly gratified by the recognition of Highmark to exclusively cover coflex^® as the only interlaminar/interspinous device treatment option for LSS.”

About Paradigm Spine, LLC

Paradigm Spine, LLC was founded in 2004 and remains focused on the design and development of solutions for the disease management of spinal stenosis. The Company’s signature product is the coflex^® Interlaminar Stabilization^®device, which has more than 20 years of clinical history and patients treated in more than 40 countries worldwide.

SOURCE Paradigm Spine, LLC


Event:			29^th Annual Piper Jaffray Healthcare Conference
Date:			Wednesday, November 29, 2017
Time:			10:30 am ET / 4:30 pm CET

Search

3 days / 6 sessions
Current Issues in Spine

Spinal Elements Announces Headquarters And CEO Changes

EIT Emerging Implant Technologies Announces First Cases Completed Successfully by Top Surgeons in the United States

Medicrea Acquires 3 Patents from Dr. Paul McAfee to Enhance Surgical Planning of 3D-Printed Titanium Interbody Devices

Contacts

Life Spine Announces Alpha Launch of SIMPACT™ TRI-FIN Sacroiliac Joint Fixation Screws

Contacts

OrthoPediatrics Corp. to Highlight its Products at the 14th Annual International Pediatric Orthopaedic Symposium

CAD Segment Expected to Comprise Nearly €57M of the Overall Europe Motion Preservation Market by 2023

Related Links

EOS imaging to Present at the 29th Annual Piper Jaffray Healthcare Conference

Contacts

Paradigm Spine, LLC Announces-Highmark, Inc. Is 1st Private Payor To Issue Exclusive Positive Coverage Policy For coflex® Interlaminar Stabilization®

Related Links

Fellowship Trained Orthopedic Spine Surgeon, Dr. Mark McFarland, Completes Successful Outpatient Surgery Using SpineFrontier’s (LES®) Technology

NuVasive To Participate In The 29th Annual Piper Jaffray Healthcare Conference

Related Links

STAR Ankle Joint Replacements Last Long Term and Provide Relief for Patients

Medacta USA’s Spine Division Begins 2017 with Key Appointment, Significant Growth

Spinal Stabilization Technologies Announces Start of LOPAIN 2 Clinical Trial in South America for Lumbar Degenerative Disc Disease

$250K Pediatric Device Competition Now Accepting Proposals

First Single-Use Rigid Endoscope to be Demonstrated at AAOS